Neuroendokrin daganatok: vizsgálatok itt: Brazília
6 trials · From ClinicalTrials.gov, checked 2026. november 14.. Ask the study team whether a trial fits you.
- No phaseTaking peopleMulticenter Study for External Validation of the TB-NET Score
- Where
- São Paulo
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
See details and how to joinNCT07903532 - 3. fázisTaking peopleDAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
- Where
- Barretos, Recife, São José do Rio Preto, São Paulo
- Életkor
- 18 év and over
- People
- 390 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07544654 · EU 2025-523869-22-00 - 2/3. fázisTaking peopleZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Porto Alegre, São Paulo
- Életkor
- 18 év and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00 - No phaseTaking peopleNeuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America
- Where
- Belo Horizonte, Cachoeiro de Itapemirim, Campo Grande, Curitiba, Lages, Londrina, Natal, Porto Alegre, Rio de Janeiro, São Paulo
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Latin American Cooperative Oncology Group
See details and how to joinNCT07192991 - 2. fázisTaking peopleStereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases
- Where
- São Paulo
- Életkor
- 18 év and over
- People
- 43
- Run by
- University of Sao Paulo
See details and how to joinNCT02185443 - 2. fázisTaking peopleEverolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
- Where
- São Paulo
- Életkor
- 16 év and over
- People
- 100
- Run by
- AC Camargo Cancer Center
See details and how to joinNCT06472388